Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. intestinal bacteria
Show results for
Products
Services

Companies

News
Articles

Refine by
Date

  • Older

Intestinal Bacteria Articles & Analysis

8 news found

CD BioGlyco Introduces HMOs Separation Service for Glycobiology Study

CD BioGlyco Introduces HMOs Separation Service for Glycobiology Study

HMOs can stimulate the growth of intestinal probiotics (such as bifidobacteria), inhibit the growth of harmful bacteria, maintain intestinal microecological balance, promote immune development, prevent necrotizing enterocolitis, promote cognitive development, and play an important role in growth and development and the development of infants. ...

ByCD BioGlyco.


New Preclinical Research Published in Nature Highlights an Active Role by Microbiome-Derived Metabolites in Brain Function and Anxiety-like Behavior

New Preclinical Research Published in Nature Highlights an Active Role by Microbiome-Derived Metabolites in Brain Function and Anxiety-like Behavior

In the murine model, the researchers used engineered gut bacteria that either constitutively produce or do not produce 4EPS. The authors demonstrated that 4EPS can enter brain tissue, and that chronic exposure to 4EPS leads to arrest of oligodendrocyte maturation and corresponding region-specific changes in myelination. ...

ByAxial Therapeutics Inc.


Creative Enzymes Launches a Weight Control Formula to Improve Intestinal Health

Creative Enzymes Launches a Weight Control Formula to Improve Intestinal Health

Later studies on lean mice found that the proportion of beneficial bacteria in the intestinal flora was much higher than that of fat mice. ...

ByCreative Enzymes


Microbiotica`s Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology

Microbiotica`s Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology

However clinical translation of this ground-breaking discovery has been hampered by large inconsistencies between studies in the intestinal bacteria associated with anti-PD1 efficacy. The Microbiotica platform is unrivalled in the comprehensiveness and precision by which it can profile the microbiome of patients. ...

ByMicrobiotica Limited


Microbiotica’s Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology

Microbiotica’s Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology

However clinical translation of this ground-breaking discovery has been hampered by large inconsistencies between studies in the intestinal bacteria associated with anti-PD1 efficacy. The Microbiotica platform is unrivalled in the comprehensiveness and precision by which it can profile the microbiome of patients. ...

ByMicrobiotica Limited


Nature communications. ATP released by intestinal bacteria limits…

Nature communications. ATP released by intestinal bacteria limits…

T cell dependent secretory IgA (SIgA) generated in the Peyer’s patches (PPs) of the small intestine shapes a broadly diverse microbiota that is crucial for host physiology. ...

ByMV BioTherapeutics SA


Symberix Awarded Multiple SBIR Grants from National Institutes of Health to Develop Proprietary Microbiome-Targeted Drugs

Symberix Awarded Multiple SBIR Grants from National Institutes of Health to Develop Proprietary Microbiome-Targeted Drugs

“Our research has demonstrated that a disease-causing component of microbiome function can be pharmacologically controlled without harming the population of beneficial bacteria. Our core technology enables identification of microbial targets that reduce drug toxicities and improve human ...

BySymberix, Inc.


Discovery of an anti-inflammatory molecule produced by gut bacteria

The researchers also showed that MAM’s effect was due to its ability to reduce the levels of certain immune system compounds in the intestinal mucosa that cause inflammation. It therefore seems that the bacteria that live in our guts protect us using the same tools as medical professionals. ...

ByINRA - French National Institute of Agronomical Research

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT